QR Code

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Abstract Nucleic acid‐based therapeutics that regulate gene expression have been developed towards clinical use at a steady pace for several decades, but in recent years the field has been accelerating. To date, there are 11 marketed products based on antisense oligonucleotides, aptamers and small i...

Description complète

Enregistré dans:
Auteurs principaux: Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela A Denti, Lourdes R Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Holodnuka, David R Jones, Sabine Krause, Taavi Lehto, Marisol Montolio, Willeke Van Roon‐Mom, Virginia Arechavala‐Gomeza
Format: Artigo
Langue:Inglês
Publié: Springer Nature 2021-04-01
Collection:EMBO Molecular Medicine
Sujets:
delivery
oligonucleotides
preclinical models
RNA therapeutics
safety
Accès en ligne:https://doi.org/10.15252/emmm.202013243
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires